Human DNA topoisomerase Inhibitors - Katkar, Prafulla
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

Topoisomerase I remains a target of active interest in the development new anticancer agents because topoisomerase I inhibitors are clearly active and effective anticancer drugs and because the current topoisomerase I inhibitors are molecules that can be improved upon. There are currently camptothecin and non-camptothecin topoisomerase I inhibitors in preclinical and clinical development. Each of these investigational molecules depicted in this book may have properties that lead to improved therapeutic bene ts to patients in future.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Topoisomerase I remains a target of active interest in the development new anticancer agents because topoisomerase I inhibitors are clearly active and effective anticancer drugs and because the current topoisomerase I inhibitors are molecules that can be improved upon. There are currently camptothecin and non-camptothecin topoisomerase I inhibitors in preclinical and clinical development. Each of these investigational molecules depicted in this book may have properties that lead to improved therapeutic bene ts to patients in future.
Autorenporträt
Dr. Prafulla Katkar, Working as an Assistant Professor of Microbiology in Guru Nanak College of Science, Ballarpur MS India. Done his Masters in Microbiology from Nagpur University and Ph.D from University of Rome "Tor Vergata" Italy. Also been awarded with honorary Doctor of Letters (D.Litt) from University of South America, Uruguay.